Schade Christian S
- SEC CIK
- 0001214496
No open-market purchases or sales filed in the past year.
Current role at each company
- IART Integra Lifesciences Holdings CorpDirectoras of May 11, 2026
- OMGA Omega Therapeutics, Inc.Directoras of Jun 21, 2024
- APRE Aprea Therapeutics, Inc.Directoras of Aug 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schade Christian S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APRE Aprea Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 (view filing) | May 18 | 1 day | Schade Christian SChairman & CEO | PPurchase | +37.5K | $0.64 | +$24.0K | +14.7%292.6K after |